Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 637953, 33 pages
http://dx.doi.org/10.1100/2012/637953
Review Article

A Comprehensive Review on Pharmacotherapeutics of Herbal Bioenhancers

Department of Pharmacology & Toxicology, College of Veterinary Science & Animal Husbandry, Sardarkrushinagar Dantiwada Agricultural University, Sardarkrushinagar 385506, Gujarat, India

Received 24 June 2012; Accepted 9 August 2012

Academic Editors: K. Ebihara and F. Song

Copyright © 2012 Ghanshyam B. Dudhatra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Atal and K. L. Bedi, “Bioenhancers: revolutionary concept to market,” Journal of Ayurveda and Integrative Medicine, vol. 1, no. 2, pp. 96–99, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. S. P. S. Khanuja, J. S. Arya, S. K. Srivastava et al., “Antibiotic pharmaceutical composition with lysergol as bioenhancer and method of treatment,” United States Patent Number, 20070060604A1, 2007.
  3. K. G. Bose, Pharmacopoeia India, Bose Laboratories, Calcutta, India, 1929.
  4. C. K. Atal, “A breakthrough in drug bioavailability-a clue from age old wisdom of Ayurveda,” IMDA Bulletin, vol. 10, pp. 483–484, 1979. View at Google Scholar
  5. G. N. Qazi, K. L. Bedi, R. K. Johri et al., “Bioavailability enhancing activity of Carum carvi extracts and fractions thereof,” United States Patent Number, US20070020347A1, 2007.
  6. P. Breedveld, J. H. Beijnen, and J. H. M. Schellens, “Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs,” Trends in Pharmacological Sciences, vol. 27, no. 1, pp. 17–24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Kang, J. Y. Cho, B. H. Shim, D. K. Kim, and J. Lee, “Bioavailability enhancing activities of natural compounds from medicinal plants,” Journal of Medicinal Plant Research, vol. 3, no. 13, pp. 1204–1211, 2009. View at Google Scholar · View at Scopus
  8. I. A. Khan, Z. M. Mirza, A. Kumar, V. Verma, and G. N. Qazi, “Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 2, pp. 810–812, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Reanmongkol, W. Janthasoot, W. Wattanatorn, P. Dhumma-Upakorn, and P. Chudapongse, “Effects of piperine on bioenergetic functions of isolated rat liver mitochondria,” Biochemical Pharmacology, vol. 37, no. 4, pp. 753–757, 1988. View at Google Scholar · View at Scopus
  10. D. S. Jamwal and J. Singh, “Effects of piperine on enzyme activities and bioenergetic functions in isolated rat liver mitochondria and hepatocytes,” Journal of Biochemical Toxicology, vol. 8, no. 4, pp. 167–174, 1993. View at Google Scholar · View at Scopus
  11. A. R. Annamalai and R. Manavalan, “Effects of “Trikatu“ and its individual components and piperine on gastro intestinal tracts: trikatu: a bioavailable enhancer,” Indian Drugs, vol. 27, no. 12, pp. 595–604, 1990. View at Google Scholar · View at Scopus
  12. R. K. Johri, N. Thusu, A. Khajuria, and U. Zutshi, “Piperine-mediated changes in the permeability of rat intestinal epithelial cells. The status of γ-glutamyl transpeptidase activity, uptake of amino acids and lipid peroxidation,” Biochemical Pharmacology, vol. 43, no. 7, pp. 1401–1407, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Majeed, V. Badmaev, and R. Rajendran, “Use of piperine to increase bioavailability of nutritional compounds,” United States Patent Number, US005536506A, 1996.
  14. S. Bajad, K. L. Bedi, A. K. Singla, and R. K. Johri, “Piperine inhibits gastric emptying and gastrointestinal transit in rats and mice,” Planta Medica, vol. 67, no. 2, pp. 176–179, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. C. K. Atal, R. K. Dubey, and J. Singh, “Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism,” Journal of Pharmacology and Experimental Therapeutics, vol. 232, no. 1, pp. 258–262, 1985. View at Google Scholar · View at Scopus
  16. R. K. Reen, D. S. Jamwal, S. C. Taneja et al., “Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine,” Biochemical Pharmacology, vol. 46, no. 2, pp. 229–238, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. R. K. Bhardwaj, H. Glaeser, L. Becquemont, U. Klotz, S. K. Gupta, and M. F. Fromm, “Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4,” Journal of Pharmacology and Experimental Therapeutics, vol. 302, no. 2, pp. 645–650, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Khajuria, N. Thusu, and U. Zutshi, “Piperine modulates permeability characteristics of intestine by inducing alterations in membrane dynamics: influence on brush border membrane fluidity, ultrastructure and enzyme kinetics,” Phytomedicine, vol. 9, no. 3, pp. 224–231, 2002. View at Google Scholar · View at Scopus
  19. M. Majeed, V. Badmaev, and R. Rajendran, “Use of piperine as a bioavailability enhancer,” United States Patent Number, 5744161, 1998.
  20. V. Badmaev, M. Majeed, and E. P. Norkus, “Piperine, an alkaloid derived from black pepper increases serum response of beta-carotene during 14-days of oral beta-carotene supplementation,” Nutrition Research, vol. 19, no. 3, pp. 381–388, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. R. D'Hooge, Y. Q. Pei, A. Raes, P. Lebrun, P. P. Van Bogaert, and P. P. De Deyn, “Anticonvulsant activity of piperine on seizures induced by excitatory amino acid receptor agonists,” Arzneimittel-Forschung/Drug Research, vol. 46, no. 6, pp. 557–560, 1996. View at Google Scholar · View at Scopus
  22. A. M. Mujumdar, J. N. Dhuley, V. K. Deshmukh, P. H. Raman, and S. R. Naik, “Anti-inflammatory activity of piperine,” Japanese Journal of Medical Science and Biology, vol. 43, no. 3, pp. 95–100, 1990. View at Google Scholar · View at Scopus
  23. S. Kumar, V. Singhal, R. Roshan, A. Sharma, G. W. Rembhotkar, and B. Ghosh, “Piperine inhibits TNF-α induced adhesion of neutrophils to endothelial monolayer through suppression of NF-κB and IκB kinase activation,” European Journal of Pharmacology, vol. 575, no. 1–3, pp. 177–186, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. V. S. Parmar, S. C. Jain, K. S. Bisht et al., “Phytochemistry of the genus Piper,” Phytochemistry, vol. 46, no. 4, pp. 597–673, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Piyachaturawa and C. Pholpramool, “Enhancement of fertilization by piperine in hamsters,” Cell Biology International, vol. 21, no. 7, pp. 405–409, 1997. View at Publisher · View at Google Scholar · View at Scopus
  26. H. M. D. Navickiene, A. C. Alécio, M. J. Kato et al., “Antifungal amides from Piper hispidum and Piper tuberculatum,” Phytochemistry, vol. 55, no. 6, pp. 621–626, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Bajad, K. L. Bedi, A. K. Singla, and R. K. Johri, “Antidiarrhoeal activity of piperine in mice,” Planta Medica, vol. 67, no. 3, pp. 284–287, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Mittal and R. L. Gupta, “in vitro antioxidant activity of piperine,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 22, no. 5, pp. 271–274, 2000. View at Google Scholar · View at Scopus
  29. K. A. Naidu and N. B. Thippeswamy, “Inhibition of human low density lipoprotein oxidation by active principles from spices,” Molecular and Cellular Biochemistry, vol. 229, no. 1-2, pp. 19–23, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. R. S. Vijayakumar, D. Surya, and N. Nalini, “Antioxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress,” Redox Report, vol. 9, no. 2, pp. 105–110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Gülçin, “The antioxidant and radical scavenging activities of black pepper (Piper nigrum) seeds,” International Journal of Food Sciences and Nutrition, vol. 56, no. 7, pp. 491–499, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Selvendiran, R. Padmavathi, V. Magesh, and D. Sakthisekaran, “Preliminary study on inhibition of genotoxicity by piperine in mice,” Fitoterapia, vol. 76, no. 3-4, pp. 296–300, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Jain and R. N. Mishra, “Antioxidant activity of Trikatu megaExt,” International Journal of Research in Pharmaceutical and Biomedical Sciences, vol. 2, pp. 624–624, 2011. View at Google Scholar
  34. C. R. Pradeep and G. Kuttan, “Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice,” Clinical and Experimental Metastasis, vol. 19, no. 8, pp. 703–708, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Panda and A. Kar, “Piperine lowers the serum concentrations of thyroid hormones, glucose and hepatic 5′D activity in adult male mice,” Hormone and Metabolic Research, vol. 35, no. 9, pp. 523–526, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. R. S. Vijayakumar and N. Nalini, “Piperine, an active principle from Piper nigrum, modulates hormonal and apolipoprotein profiles in hyperlipidemic rats,” Journal of Basic and Clinical Physiology and Pharmacology, vol. 17, no. 2, pp. 71–86, 2006. View at Google Scholar · View at Scopus
  37. R. El Hamss, M. Idaomar, A. Alonso-Moraga, and A. Muñoz Serrano, “Antimutagenic properties of bell and black peppers,” Food and Chemical Toxicology, vol. 41, no. 1, pp. 41–47, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Selvendiran, S. M. Banu, and D. Sakthisekaran, “Oral supplementation of piperine leads to altered phase II enzymes and reduced DNA damage and DNA-protein cross links in Benzo(a)pyrene induced experimental lung carcinogenesis,” Molecular and Cellular Biochemistry, vol. 268, no. 1-2, pp. 141–147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Srinivasan, “Black pepper and its pungent principle-piperine: a review of diverse physiological effects,” Critical Reviews in Food Science and Nutrition, vol. 47, no. 8, pp. 735–748, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Wongpa, L. Himakoun, S. Soontornchai, and P. Temcharoen, “Antimutagenic effects of piperine on cyclophosphamide-induced chromosome aberrations in rat bone marrow cells,” Asian Pacific Journal of Cancer Prevention, vol. 8, no. 4, pp. 623–627, 2007. View at Google Scholar · View at Scopus
  41. E. S. Sunila and G. Kuttan, “Immunomodulatory and antitumor activity of Piper longum Linn. and piperine,” Journal of Ethnopharmacology, vol. 90, no. 2-3, pp. 339–346, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Manoharan, S. Balakrishnan, V. P. Menon, L. M. Alias, and A. R. Reena, “Chemopreventive & efficacy of curcumin and piperine during 7,12-dimethylbenz (a)anthracene-induced hamster buccal pouch carcinogenesis,” Singapore Medical Journal, vol. 50, no. 2, pp. 139–146, 2009. View at Google Scholar · View at Scopus
  43. S. A. Lee, S. S. Hong, X. H. Han et al., “Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity,” Chemical and Pharmaceutical Bulletin, vol. 53, no. 7, pp. 832–835, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Li, C. Wang, M. Wang, W. Li, K. Matsumoto, and Y. Tang, “Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms,” Life Sciences, vol. 80, no. 15, pp. 1373–1381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Wattanathorn, P. Chonpathompikunlert, S. Muchimapura, A. Priprem, and O. Tankamnerdthai, “Piperine, the potential functional food for mood and cognitive disorders,” Food and Chemical Toxicology, vol. 46, no. 9, pp. 3106–3110, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. B. S. Park, D. J. Son, Y. H. Park, T. W. Kim, and S. E. Lee, “Antiplatelet effects of acidamides isolated from the fruits of Piper longum L,” Phytomedicine, vol. 14, no. 12, pp. 853–855, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Pooja, R. P. Agrawal, P. Nyati, V. Savita, and P. Phadnis, “Analgesic activity ofPiper nigrumextract per se and its interaction with diclofenac sodium and pentazocine in albino mice,” The Internet Journal of Pharmacology, vol. 5, no. 1, p. 3, 2007. View at Google Scholar
  48. H. Matsuda, K. Ninomiya, T. Morikawa, D. Yasuda, I. Yamaguchi, and M. Yoshikawa, “Protective effects of amide constituents from the fruit of Piper chaba on d-galactosamine/TNF-α-induced cell death in mouse hepatocytes,” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 6, pp. 2038–2042, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. S. I. H. Taqvi, A. J. Shah, and A. H. Gilani, “Blood pressure lowering and vasomodulator effects of piperine,” Journal of Cardiovascular Pharmacology, vol. 52, no. 5, pp. 452–458, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. S. H. Kim and Y. C. Lee, “Piperine inhibits eosinophil infiltration and airway hyperresponsiveness by suppressing T cell activity and Th2 cytokine production in the ovalbumin-induced asthma model,” Journal of Pharmacy and Pharmacology, vol. 61, no. 3, pp. 353–359, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. I. B. Koul and A. Kapil, “Evaluation of the liver protective potential of piperine, an active principle of black and long peppers,” Planta Medica, vol. 59, no. 5, pp. 413–417, 1993. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Unchern, H. Saito, and N. Nishiyama, “Selective cytotoxicity of piperine on cultured rat hippocampal neurons in comparison with cultured astrocytes: the possible involvement of lipid peroxidation,” Biological and Pharmaceutical Bulletin, vol. 20, no. 9, pp. 958–961, 1997. View at Google Scholar · View at Scopus
  53. M. B. Daware, A. M. Mujumdar, and S. Ghaskadbi, “Reproductive toxicity of piperine in Swiss albino mice,” Planta Medica, vol. 66, no. 3, pp. 231–236, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. R. K. S. Dogra, S. Khanna, and R. Shanker, “Immunotoxicological effects of piperine in mice,” Toxicology, vol. 196, no. 3, pp. 229–236, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. J. Singh, R. K. Reen, and F. J. Wiebel, “Piperine, a major ingredient of black and long peppers, protects against AFB1-induced cytotoxicity and micronuclei formation in H4IIEC3 rat hepatoma cells,” Cancer Letters, vol. 86, no. 2, pp. 195–200, 1994. View at Publisher · View at Google Scholar · View at Scopus
  56. R. K. Reen, F. J. Wiebel, and J. Singh, “Piperine inhibits aflatoxin B1-induced cytotoxicity and genotoxicity in V79 Chinese hamster cells genetically engineered to express rat cytochrome P4502B1,” Journal of Ethnopharmacology, vol. 58, no. 3, pp. 165–173, 1997. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Khajuria, N. Thusu, U. Zutshi, and K. L. Bedi, “Piperine modulation of carcinogen induced oxidative stress in intestinal mucosa,” Molecular and Cellular Biochemistry, vol. 189, no. 1-2, pp. 113–118, 1998. View at Google Scholar · View at Scopus
  58. K. Selvendiran, S. M. Banu, and D. Sakthisekaran, “Protective effect of piperine on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice,” Clinica Chimica Acta, vol. 350, no. 1-2, pp. 73–78, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Selvendiran, J. P. V. Singh, K. B. Krishnan, and D. Sakthisekaran, “Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice,” Fitoterapia, vol. 74, no. 1-2, pp. 109–115, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Selvendiran, P. Senthilnathan, V. Magesh, and D. Sakthisekaran, “Modulatory effect of Piperine on mitochondrial antioxidant system in Benzo(a)pyrene-induced experimental lung carcinogenesis,” Phytomedicine, vol. 11, no. 1, pp. 85–89, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Selvendiran, C. Thirunavukkarasu, J. P. V. Singh, R. Padmavathi, and D. Sakthisekaran, “Chemopreventive effect of piperine on mitochondrial TCA cycle and phase-I and glutathione-metabolizing enzymes in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice,” Molecular and Cellular Biochemistry, vol. 271, no. 1-2, pp. 101–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. B. M. Choi, S. M. Kim, T. K. Park et al., “Piperine protects cisplatin-induced apoptosis via heme oxygenase-1 induction in auditory cells,” Journal of Nutritional Biochemistry, vol. 18, no. 9, pp. 615–622, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Q. Zhao, G. Z. Du, Y. C. Xiong, Y. F. Wen, M. Bhadauria, and S. K. Nirala, “Attenuation of beryllium induced hepatorenal dysfunction and oxidative stress in rodents by combined effect of gallic acid and piperine,” Archives of Pharmacal Research, vol. 30, no. 12, pp. 1575–1583, 2007. View at Google Scholar · View at Scopus
  64. N. Pathak and S. Khandelwal, “Comparative efficacy of piperine, curcumin and picroliv against Cd immunotoxicity in mice,” BioMetals, vol. 21, no. 6, pp. 649–661, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. P. Piyachaturawat, T. Glinsukon, and C. Toskulkao, “Acute and subacute toxicity of piperine in mice, rats and hamsters,” Toxicology Letters, vol. 16, no. 3-4, pp. 351–359, 1983. View at Google Scholar · View at Scopus
  66. J. Singh, R. K. Dubey, and C. K. Atal, “Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogeneous UDP-glucuronic acid content,” Journal of Pharmacology and Experimental Therapeutics, vol. 236, no. 2, pp. 488–493, 1986. View at Google Scholar · View at Scopus
  67. J. R. Stöhr, P. G. Xiao, and R. Bauer, “Constituents of Chinese Piper species and their inhibitory activity on prostaglandin and leukotriene biosynthesis in vitro,” Journal of Ethnopharmacology, vol. 75, no. 2-3, pp. 133–139, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Allameh, M. Saxena, G. Biswas, H. G. Raj, J. Singh, and N. Srivastava, “Piperine, a plant alkaloid of the piper species, enhances the bioavailability of aflatoxin B1 in rat tissues,” Cancer Letters, vol. 61, no. 3, pp. 195–199, 1992. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Malini, R. R. Manimaran, J. Arunakaran, M. M. Aruldhas, and P. Govindarajulu, “Effects of piperine on testis of albino rats,” Journal of Ethnopharmacology, vol. 64, no. 3, pp. 219–225, 1999. View at Publisher · View at Google Scholar · View at Scopus
  70. S. A. Dhanukar, A. B. Kapadia, and S. M. Karandikar, “Influence of Trikatu powder on rifampicin bioavailability,” Indian Drugs, vol. 20, pp. 402–404, 1983. View at Google Scholar
  71. R. S. Karan, V. K. Bhargava, and S. K. Garg, “Effect of trikatu, an Ayurvedic prescription, on the pharmacokinetic profile of rifampicin in rabbits,” Journal of Ethnopharmacology, vol. 64, no. 3, pp. 259–264, 1999. View at Publisher · View at Google Scholar · View at Scopus
  72. R. S. Karan, V. K. Bhargava, and S. K. Garg, “Effect of Trikatu (PIPERINE) on the pharmacokinetic profile of isoniazld in rabbits,” Indian Journal of Pharmacology, vol. 30, no. 4, pp. 254–256, 1998. View at Google Scholar · View at Scopus
  73. L. G. Lala, P. M. D'Mello, and S. R. Naik, “Pharmacokinetic and pharmacodynamic studies on interaction of “trikatu” with diclofenac sodium,” Journal of Ethnopharmacology, vol. 91, no. 2-3, pp. 277–280, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. U. Zutshi and J. L. Kaul, “The impact of Ayurvedic herbals on drug bioavailability,” Indian Drugs, vol. 19, pp. 476–479, 1982. View at Google Scholar
  75. U. Zutshi, “A process for the preparation of pharmaceutical combination with enhanced activity for treatment of tuberculosis and leprosy,” Indian Patent No. 1232/DEL/89, 1989.
  76. G. Bano, V. Amla, R. K. Raina, U. Zutshi, and C. L. Chopra, “The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers,” Planta Medica, vol. 53, no. 6, pp. 568–569, 1987. View at Google Scholar · View at Scopus
  77. G. Bano, R. K. Raina, U. Zutshi, K. L. Bedi, R. K. Johri, and S. C. Sharma, “Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers,” European Journal of Clinical Pharmacology, vol. 41, no. 6, pp. 615–617, 1991. View at Publisher · View at Google Scholar · View at Scopus
  78. A. M. Mujumdar, J. N. Dhuley, V. K. Deshmukh, P. H. Raman, S. L. Thorat, and S. R. Naik, “Effect of piperine on pentobarbitone induced hypnosis in rats,” Indian Journal of Experimental Biology, vol. 28, no. 5, pp. 486–487, 1990. View at Google Scholar · View at Scopus
  79. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P. S. S. R. Srinivas, “Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers,” Planta Medica, vol. 64, no. 4, pp. 353–356, 1998. View at Publisher · View at Google Scholar · View at Scopus
  80. J. Shaikh, D. D. Ankola, V. Beniwal, D. Singh, and M. N. V. R. Kumar, “Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer,” European Journal of Pharmaceutical Sciences, vol. 37, no. 3-4, pp. 223–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. D. Suresh and K. Srinivasan, “Tissue distribution & elimination of capsaicin, piperine & curcumin following oral intake in rats,” Indian Journal of Medical Research, vol. 131, no. 5, pp. 682–691, 2010. View at Google Scholar · View at Scopus
  82. S. K. Gupta, T. Velpandian, S. Sengupta, P. Mathur, and P. Sapra, “Influence of piperine on nimesulide induced antinociception,” Phytotherapy Research, vol. 12, pp. 266–269, 1998. View at Google Scholar
  83. R. S. Karan, V. K. Bhargava, and S. K. Garg, “Effect of trikatu on the pharmacokinetic profile of indomethacin in rabbits,” Indian Journal of Pharmacology, vol. 31, no. 2, pp. 160–161, 1999. View at Google Scholar · View at Scopus
  84. A. M. Mujumdar, J. N. Dhuley, V. K. Deshmukh, and S. R. Naik, “Effect of piperine on bioavailability of oxyphenylbutazone in rats,” Indian Drugs, vol. 36, no. 2, pp. 123–126, 1999. View at Google Scholar · View at Scopus
  85. T. Velpandian, R. Jasuja, R. K. Bhardwaj, J. Jaiswal, and S. K. Gupta, “Piperine in food: interference in the pharmacokinetics of phenytoin,” European Journal of Drug Metabolism and Pharmacokinetics, vol. 26, no. 4, pp. 241–247, 2001. View at Google Scholar · View at Scopus
  86. S. Pattanaik, D. Hota, S. Prabhakar, P. Kharbanda, and P. Pandhi, “Effect of piperine on the steady-state pharmacokinetics of phenytoin in patients with epilepsy,” Phytotherapy Research, vol. 20, no. 8, pp. 683–686, 2006. View at Publisher · View at Google Scholar · View at Scopus
  87. R. K. Zutshi, R. Singh, U. Zutshi, R. K. Johri, and C. K. Atal, “Influence of piperine on rifampicin blood levels in patients of pulmonary tuberculosis,” The Journal of the Association of Physicians of India, vol. 33, no. 3, pp. 223–224, 1985. View at Google Scholar · View at Scopus
  88. V. Balakrishnan, S. Varma, and D. Chatterji, “Piperine augments transcription inhibitory activity of rifampicin by severalfold in Mycobacterium smegmatis,” Current Science, vol. 80, no. 10, pp. 1302–1305, 2001. View at Google Scholar · View at Scopus
  89. A. R. Hiwale, J. N. Dhuley, and S. R. Naik, “Effect of co-administration of piperine on pharmacokinetics of β-lactam antibiotics in rats,” Indian Journal of Experimental Biology, vol. 40, no. 3, pp. 277–281, 2002. View at Google Scholar · View at Scopus
  90. J. D. Lambert, J. Hong, D. H. Kim, V. M. Mishin, and C. S. Yang, “Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice,” Journal of Nutrition, vol. 134, no. 8, pp. 1948–1952, 2004. View at Google Scholar · View at Scopus
  91. M. Singh, C. Varshneya, R. S. Telang, and A. K. Srivastava, “Alteration of pharmacokinetics of oxytetracycline following oral administration of Piper longum in hens,” Journal of Veterinary Science, vol. 6, no. 3, pp. 197–200, 2005. View at Google Scholar · View at Scopus
  92. B. S. Balkrishna and P. V. Yogesh, “Influence of co-administration of piperine on pharmacokinetic profile of ciprofloxacin,” Indian Drugs, vol. 39, no. 3, pp. 166–168, 2002. View at Google Scholar · View at Scopus
  93. R. Kasibhatta and M. U. R. Naidu, “Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions: a randomised, crossover, placebo-controlled study,” Drugs in R and D, vol. 8, no. 6, pp. 383–391, 2007. View at Google Scholar · View at Scopus
  94. M. S. Dama, C. Varshneya, M. S. Dardi, and V. C. Katoch, “Effect of trikatu pretreatment on the pharmacokinetics of pefloxacin administered orally in mountain Gaddi goats,” Journal of Veterinary Science, vol. 9, no. 1, pp. 25–29, 2008. View at Google Scholar · View at Scopus
  95. K. Janakiraman and R. Manavalan, “Compatibility and stability studies of ampicillin trihydrate and piperine mixture,” International Journal of Pharmaceutical Sciences and Research, vol. 2, pp. 1176–1181, 2008. View at Google Scholar
  96. S. Pattanaik, D. Hota, S. Prabhakar, P. Kharbanda, and P. Pandhi, “Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients,” Phytotherapy Research, vol. 23, no. 9, pp. 1281–1286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. M. J. Jin and H. K. Han, “Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction,” Journal of Food Science, vol. 75, no. 3, pp. H93–H96, 2010. View at Publisher · View at Google Scholar · View at Scopus
  98. A. Singh, V. K. Pawar, V. Jakhmola, M. H. Parabia, R. Awasthi, and G. Sharma, “In vivo assessment of enhanced bioavailability of metronidazole with piperine in rabbits,” Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 1, no. 4, pp. 273–278, 2010. View at Google Scholar · View at Scopus
  99. K. Janakiraman and R. Manavalan, “Studies on effect of piperine on oral bioavailability of ampicillin and norfloxacin,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 5, pp. 257–262, 2011. View at Google Scholar
  100. J. J. Johnson, M. Nihal, I. A. Siddiqui et al., “Enhancing the bioavailability of resveratrol by combining it with piperine,” Molecular Nutrition and Food Research, vol. 55, no. 8, pp. 1169–1176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Patel, S. Devada, H. Patel, N. Patel, S. Bhavsar, and A. Thaker, “Influence of co-administration of piperine on pharmacokinetic profile of gatifloxacin in layer birds,” Global Veterinaria, vol. 7, pp. 427–432, 2011. View at Google Scholar
  102. S. S. Devada, S. D. Patel, H. B. Patel, N. N. Patel, S. K. Bhavsar, and A. M. Thaker, “Bioenhancing activity of piperine on pharmacokinetics of gatifloxacin in broiler birds,” Inventi Impact: Planta Activa, vol. 2011, Article ID: Inventi:ppa/10/11, 2011, http://www.inventi.in/Article/ppa/10/11.aspx.
  103. A. Singh and S. Chand, “Improved bioavailability of atenolol with piperine in rats,” International Journal of Pharmaceutical Research, vol. 3, pp. 88–91, 2011. View at Google Scholar
  104. S. Venkatesh, K. D. Durga, Y. Padmavathi, B. M. Reddy, and R. Mullangi, “Influence of piperine on ibuprofen induced antinociception and its pharmacokinetics,” Drug Research, vol. 61, pp. 506–509, 2011. View at Google Scholar
  105. A. Singh, D. A. Jain, S. Kumar, N. Jaishwal, R. K. Singh, and P. S. Patel, “Enhanced bioavailability of losartan potassium with piperine in rats,” International Journal of Pharmacy Research and Technology, vol. 2, pp. 34–36, 2012. View at Google Scholar
  106. V. Badmaev, M. Majeed, and L. Prakash, “Piperine derived from black pepper increases the plasma levels of coenzyme Q10 following oral supplementation,” Journal of Nutritional Biochemistry, vol. 11, no. 2, pp. 109–113, 2000. View at Publisher · View at Google Scholar · View at Scopus
  107. R. S. Kapil, U. Zutshi, K. L. Bedi et al., “Process of preparation of pharmaceutical composition with enhanced activity for treatment of tuberculosis and leprosy,” United States Patent Number, US005439891A, 1995.
  108. R. S. Kapil, U. Zutshi, K. L. Bedi et al., “Pharmaceutical compositions containing piperine and an antituberculosis or antileprosy drug,” European Patent Number, EP0650728B1, 2002.
  109. P. C. Chawla, “Resorine:a novel CSIR drug curtails TB treatment,” CSIR News, vol. 60, pp. 52–54, 2010. View at Google Scholar
  110. V. S. Govindarajan, “Ginger-chemistry, technology, and quality evaluation: part 2,” Critical Reviews in Food Science and Nutrition, vol. 17, no. 3, pp. 189–258, 1982. View at Google Scholar · View at Scopus
  111. S. D. Jolad, R. C. Lantz, A. M. Solyom, G. J. Chen, R. B. Bates, and B. N. Timmermann, “Fresh organically grown ginger (Zingiber officinale): composition and effects on LPS-induced PGE2 production,” Phytochemistry, vol. 65, no. 13, pp. 1937–1954, 2004. View at Publisher · View at Google Scholar · View at Scopus
  112. W. C. Evans, Ginger. Trease and Evans Pharmacognosy, WB Saunders, Edinburgh, UK, 15th edition, 2002.
  113. M. O'Hara, D. Kiefer, K. Farrell, and K. Kemper, “A review of 12 commonly used medicinal herbs,” Archives of Family Medicine, vol. 7, no. 6, pp. 523–536, 1998. View at Google Scholar · View at Scopus
  114. A. A. Oyagbemi, A. B. Saba, and O. I. Azeez, “Molecular targets of [6]-gingerol: its potential roles in cancer chemoprevention,” BioFactors, vol. 36, no. 3, pp. 169–178, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Yamahara, M. Mochizuki, H. Q. Rong, H. Matsuda, and H. Fujimura, “The anti-ulcer effect in rats of ginger constituents,” Journal of Ethnopharmacology, vol. 23, no. 2-3, pp. 299–304, 1988. View at Google Scholar · View at Scopus
  116. H. Wu, D. Ye, Y. Bai, and Y. Zhao, “Effect of dry ginger and roasted ginger on experimental gastric ulcers in rats,” China Journal of Chinese Materia Medica, vol. 15, no. 5, pp. 278–317, 1990. View at Google Scholar · View at Scopus
  117. M. Thomson, K. K. Al-Qattan, S. M. Al-Sawan, M. A. Alnaqeeb, I. Khan, and M. Ali, “The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 67, no. 6, pp. 475–478, 2002. View at Publisher · View at Google Scholar · View at Scopus
  118. G. C. Jagetia, M. S. Baliga, P. Venkatesh, and J. N. Ulloor, “Influence of ginger rhizome (Zingiber officinale Rosc) on survival, glutathione and lipid peroxidation in mice after whole-body exposure to Gamma radiation,” Radiation Research, vol. 160, no. 5, pp. 584–592, 2003. View at Publisher · View at Google Scholar · View at Scopus
  119. C. Ficker, M. L. Smith, K. Akpagana et al., “Bioassay-guided isolation and identification of antifungal compounds from ginger,” Phytotherapy Research, vol. 17, no. 8, pp. 897–902, 2003. View at Publisher · View at Google Scholar · View at Scopus
  120. R. Grzanna, L. Lindmark, and C. G. Frondoza, “Ginger-an herbal medicinal product with broad anti-inflammatory actions,” Journal of Medicinal Food, vol. 8, no. 2, pp. 125–132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  121. J. A. O. Ojewole, “Analgesic, antiinflammatory and hypoglycaemic effects of ethanol extract of Zingiber officinale (Roscoe) rhizomes (Zingiberaceae) in mice and rats,” Phytotherapy Research, vol. 20, no. 9, pp. 764–772, 2006. View at Publisher · View at Google Scholar · View at Scopus
  122. J. K. Kim, Y. Kim, K. M. Na, Y. J. Surh, and T. Y. Kim, “[6]-gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo,” Free Radical Research, vol. 41, no. 5, pp. 603–614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. Z. M. Al-Amin, M. Thomson, K. K. Al-Qattan, and M. Ali, “Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats,” British Journal of Nutrition, vol. 96, no. 4, pp. 660–666, 2006. View at Publisher · View at Google Scholar · View at Scopus
  124. S. A. Boone and K. M. Shields, “Treating pregnancy-related nausea and vomiting with ginger,” Annals of Pharmacotherapy, vol. 39, no. 10, pp. 1710–1713, 2005. View at Publisher · View at Google Scholar · View at Scopus
  125. N. Chaiyakunapruk, N. Kitikannakorn, S. Nathisuwan, K. Leeprakobboon, and C. Leelasettagool, “The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis,” American Journal of Obstetrics and Gynecology, vol. 194, no. 1, pp. 95–99, 2006. View at Publisher · View at Google Scholar · View at Scopus
  126. Z. Iqbal, M. Lateef, M. S. Akhtar, M. N. Ghayur, and A. H. Gilani, “In vivo anthelmintic activity of ginger against gastrointestinal nematodes of sheep,” Journal of Ethnopharmacology, vol. 106, no. 2, pp. 285–287, 2006. View at Publisher · View at Google Scholar · View at Scopus
  127. Y. Shukla and M. Singh, “Cancer preventive properties of ginger: a brief review,” Food and Chemical Toxicology, vol. 45, no. 5, pp. 683–690, 2007. View at Publisher · View at Google Scholar · View at Scopus
  128. G. N. Qazi, K. L. Bedi, R. K. Johri et al., “Bioavailability enhancing activity of Zingiber officinale and its extracts/fractions thereof,” United States Patent Number, US2003/0170326A1, 2003.
  129. G. N. Qazi, C. L. Tikoo, A. K. Gupta et al., “Bioavailability enhancing activity of Zingiber officinale Linn and its extracts/fractions thereof,” World Intellectual Property Organization, International Publication Number, WO03049753A1, 2003.
  130. K. Shanker, M. M. Gupta, S. K. Srivastava, D. U. Bawankule, A. Pal, and S. P. S. Khanuja, “Determination of bioactive nitrile glycoside(s) in drumstick (Moringa oleifera) by reverse phase HPLC,” Food Chemistry, vol. 105, no. 1, pp. 376–382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  131. S. Shukla, R. Mathur, and A. O. Prakash, “Antifertility profile of the aqueous extract of Moringa oleifera roots,” Journal of Ethnopharmacology, vol. 22, no. 1, pp. 51–62, 1988. View at Google Scholar · View at Scopus
  132. A. Caceres, O. Cabrera, O. Morales, P. Mollinedo, and P. Mendia, “Pharmacological properties of Moringa oleifera. 1: preliminary screening for antimicrobial activity,” Journal of Ethnopharmacology, vol. 33, no. 3, pp. 213–216, 1991. View at Google Scholar · View at Scopus
  133. A. Caceres, A. Saravia, S. Rizzo, L. Zabala, E. De Leon, and F. Nave, “Pharmacologic properties of Moringa oleifera. 2: screening for antispasmodic, antiinflammatory and diuretic activity,” Journal of Ethnopharmacology, vol. 36, no. 3, pp. 233–237, 1992. View at Publisher · View at Google Scholar · View at Scopus
  134. K. Aruna and V. M. Sivaramakrishnan, “Anticarcinogenic effects of some Indian plant products,” Food and Chemical Toxicology, vol. 30, no. 11, pp. 953–956, 1992. View at Publisher · View at Google Scholar · View at Scopus
  135. A. P. Guevara and C. Vargas, “Anti-inflammatory and antitumor activities of seed extracts of malunggay,Moringa oleiferaL. (Moringaceae),” Philippine Journal of Science, vol. 125, pp. 175–184, 1996. View at Google Scholar
  136. A. H. Gilani, K. Aftab, A. Suria et al., “Pharmacological studies on hypotensive and spasmolytic activities of pure compounds from Moringa oleifera,” Phytotherapy Research, vol. 8, no. 2, pp. 87–91, 1994. View at Google Scholar · View at Scopus
  137. M. O. Nwosu and J. I. Okafor, “Preliminary studies of the antifungal activities of some medicinal plants against Basidiobolus and some other pathogenic fungi,” Mycoses, vol. 38, no. 5-6, pp. 191–195, 1995. View at Google Scholar · View at Scopus
  138. S. K. Pal, P. K. Mukherjee, and B. P. Saha, “Studies on the antiulcer activity of Moringa oleifera leaf extract on gastric ulcer models in rats,” Phytotherapy Research, vol. 9, no. 6, pp. 463–465, 1995. View at Publisher · View at Google Scholar · View at Scopus
  139. P. Siddhuraju and K. Becker, “Antioxidant properties of various solvent extracts of total phenolic constituents from three different agroclimatic origins of drumstick tree (Moringa oleifera Lam.) leaves,” Journal of Agricultural and Food Chemistry, vol. 51, no. 8, pp. 2144–2155, 2003. View at Publisher · View at Google Scholar · View at Scopus
  140. N. Oinam, A. Urooj, P. P. Phillips, and N. P. Niranjan, “Effect of dietary lipids and drumstick leaves (Moringa oleifera) on lipid profile and antioxidant parameters in rats,” Food and Nutrition Sciences, vol. 3, pp. 141–145, 2012. View at Google Scholar
  141. L. Pari and N. A. Kumar, “Hepatoprotective activity of Moringa oleifera on antitubercular drug-induced liver damage in rats,” Journal of Medicinal Food, vol. 5, no. 3, pp. 171–177, 2002. View at Google Scholar · View at Scopus
  142. L. K. Mehta, R. Balaraman, A. H. Amin, P. A. Bafna, and O. D. Gulati, “Effect of fruits of Moringa oleifera on the lipid profile of normal and hypercholesterolaemic rabbits,” Journal of Ethnopharmacology, vol. 86, no. 2-3, pp. 191–195, 2003. View at Publisher · View at Google Scholar · View at Scopus
  143. K. B. Saravillo and A. A. Herrera, “Biological activity of Moringa oleifera Lam. (Malunggay) crude seed extract,” Philippine Agricultural Scientist, vol. 87, no. 1, pp. 96–100, 2004. View at Google Scholar · View at Scopus
  144. S. G. Mahajan, R. G. Mali, and A. A. Mehta, “Protective effect of ethanolic extract of seeds of Moringa oleifera Lam. against inflammation associated with development of arthritis in rats,” Journal of Immunotoxicology, vol. 4, no. 1, pp. 39–47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  145. S. P. S. Khanuja, J. S. Arya, T. Ranganathan et al., “Nitrile glycoside useful as a bioenhancer of drugs and nutrients, process of its isolation from Moringa oleifera,” United States Patent Number, US006858588B2, 2005.
  146. S. P. S. Khanuja, J. S. Arya, T. Ranganathan et al., “Nitrile glycoside useful as a bioenhancer of drugs and nutrients, process of its isolation from Moringa oleifera,” European Patent Number, EP1611148B1, 2008.
  147. Y. Kiso, M. Tohkin, and H. Hikino, “Mechanism of antihepatotoxic activity of glycyrrhizin, I: effect on free radical generation and lipid peroxidation,” Planta Medica, vol. 50, no. 4, pp. 298–302, 1984. View at Google Scholar · View at Scopus
  148. M. Nose, M. Ito, K. Kamimura, M. Shimizu, and Y. Ogihara, “A comparison of the antihepatotoxic activity between glycyrrhizin and glycyrrhetinic acid,” Planta Medica, vol. 60, no. 2, pp. 136–139, 1994. View at Google Scholar · View at Scopus
  149. H. Akamatsu, J. Komura, Y. Asada, and Y. Niwa, “Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation,” Planta Medica, vol. 57, no. 2, pp. 119–121, 1991. View at Google Scholar · View at Scopus
  150. Y. Fujisawa, M. Sakamoto, M. Matsushita, T. Fujita, and K. Nishioka, “Glycyrrhizin inhibits the lytic pathway of complement—possible mechanism of its anti-inflammatory effect on liver cells in viral hepatitis,” Microbiology and Immunology, vol. 44, no. 9, pp. 799–804, 2000. View at Google Scholar · View at Scopus
  151. S. Shibata, “Antitumor promoting and anti-inflammatory activities of licorice principles and their modified compounds,” Food Phytochemicals for Cancer Prevention-II, vol. 31, pp. 308–321, 1994. View at Google Scholar
  152. T. Utsunomiya, M. Kobayashi, R. B. Pollard, and F. Suzuki, “Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 3, pp. 551–556, 1997. View at Google Scholar · View at Scopus
  153. J. M. Crance, N. Scaramozzino, A. Jouan, and D. Garin, “Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses,” Antiviral Research, vol. 58, no. 1, pp. 73–79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  154. S. P. S. Khanuja, S. Kumar, J. S. Arya et al., “Composition comprising pharmaceutical/nutraceutical agent and a bioenhancer obtained from Glycyrrhiza glabra,” United States Patent Number, US006979471B1, 2005.
  155. S. P. S. Khanuja, S. Kumar, J. S. Arya et al., “Composition comprising pharmaceutical/nutraceutical agent and a bioenhancer obtained from Glycyrrhiza glabra,” United States Patent Number, US20060057234A1, 2006.
  156. N. S. Iacobellis, P. Lo Cantore, F. Capasso, and F. Senatore, “Antibacterial activity of Cuminum cyminum L. and Carum carvi L. essential oils,” Journal of Agricultural and Food Chemistry, vol. 53, no. 1, pp. 57–61, 2005. View at Publisher · View at Google Scholar · View at Scopus
  157. T. Malini and G. Vanithakumari, “Estrogenic activity of Cuminum cyminum in rats,” Indian Journal of Experimental Biology, vol. 25, no. 7, pp. 442–444, 1987. View at Google Scholar · View at Scopus
  158. S. Dhandapani, V. R. Subramanian, S. Rajagopal, and N. Namasivayam, “Hypolipidemic effect of Cuminum cyminum L. on alloxan-induced diabetic rats,” Pharmacological Research, vol. 46, no. 3, pp. 251–255, 2002. View at Publisher · View at Google Scholar · View at Scopus
  159. M. Sayyah, A. Peirovi, and M. Kamalinejad, “Anti-nociceptive effect of the fruit essential oil of Cuminum cyminum L. in rat,” Iranian Biomedical Journal, vol. 6, no. 4, pp. 141–145, 2002. View at Google Scholar · View at Scopus
  160. M. Sayyah, A. Mahboubi, and M. Kamalinejad, “Anticonvulsant effect of the fruit essential oil of Cuminum cyminum in mice,” Pharmaceutical Biology, vol. 40, no. 6, pp. 478–480, 2002. View at Publisher · View at Google Scholar · View at Scopus
  161. Gagandeep, S. Dhanalakshmi, E. Méndiz, A. R. Rao, and R. K. Kale, “Chemopreventive effects of Cuminum cyminum in chemically induced forestomach and uterine cervix tumors in murine model systems,” Nutrition and Cancer, vol. 47, no. 2, pp. 171–180, 2003. View at Google Scholar · View at Scopus
  162. L. Gachkar, D. Yadegari, M. B. Rezaei, M. Taghizadeh, S. A. Astaneh, and I. Rasooli, “Chemical and biological characteristics of Cuminum cyminum and Rosmarinus officinalis essential oils,” Food Chemistry, vol. 102, no. 3, pp. 898–904, 2007. View at Publisher · View at Google Scholar · View at Scopus
  163. M. H. Boskabady, S. Kiani, H. Azizi, and T. Khatami, “Antitussive effect of Cuminum cyminum Linn. in guinea pigs,” Natural Product Radiance, vol. 5, pp. 266–269, 2006. View at Google Scholar
  164. A. H. El-Ghorab, M. Nauman, F. M. Anjum, S. Hussain, and M. Nadeem, “A Comparative study on chemical composition and antioxidant activity of ginger (Zingiber officinale) and cumin (Cuminum cyminum),” Journal of Agricultural and Food Chemistry, vol. 58, no. 14, pp. 8231–8237, 2010. View at Publisher · View at Google Scholar · View at Scopus
  165. M. B. H. Pai, G. M. Prashant, K. S. Murlikrishna, K. M. Shivakumar, and G. N. Chandu, “Antifungal efficacy of Punica granatum, Acacia nilotica, Cuminum cyminum and Foeniculum vulgare on Candida albicans: an in vitro study,” Indian Journal of Dental Research, vol. 21, no. 3, pp. 334–336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  166. G. N. Qazi, K. L. Bedi, R. K. Johri et al., “Bioavailability enhancing activity of Cuminum cyminum extracts and fractions thereof,” World Intellectual Property Organization, International Publication Number, WO03075685A2, 2003.
  167. G. N. Qazi, K. L. Bedi, R. K. Johri et al., “Bioavailability/bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereof,” United States Patent Number, US007514105B2, 2009.
  168. H. Toxopeus and H. J. Bouwmeester, “Improvement of caraway essential oil and carvone production in The Netherlands,” Industrial Crops and Products, vol. 1, no. 2–4, pp. 295–301, 1992. View at Google Scholar · View at Scopus
  169. M. T. Khayyal, M. A. El-Ghazaly, S. A. Kenawy et al., “Antiulcerogenic effect of some gastrointestinally acting plant extracts and their combination,” Arzneimittel-Forschung/Drug Research, vol. 51, no. 7, pp. 545–553, 2001. View at Google Scholar · View at Scopus
  170. M. Eddouks, A. Lemhadri, and J. B. Michel, “Caraway and caper: potential anti-hyperglycaemic plants in diabetic rats,” Journal of Ethnopharmacology, vol. 94, no. 1, pp. 143–148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  171. L. De Martino, V. De Feo, F. Fratianni, and F. Nazzaro, “Chemistry, antioxidant, antibacterial and antifungal activities of volatile oils and their components,” Natural Product Communications, vol. 4, no. 12, pp. 1741–1750, 2009. View at Google Scholar · View at Scopus
  172. S. Lahlou, A. Tahraoui, Z. Israili, and B. Lyoussi, “Diuretic activity of the aqueous extracts of Carum carvi and Tanacetum vulgare in normal rats,” Journal of Ethnopharmacology, vol. 110, no. 3, pp. 458–463, 2007. View at Publisher · View at Google Scholar · View at Scopus
  173. A. Najda, J. Dyduch, and N. Brzozowski, “Flavonoid content and antioxidant activity of caraway roots (Carum carviL,” Vegetable Crops Research Bulletin, vol. 68, pp. 127–133, 2008. View at Google Scholar
  174. M. R. Abyaneh, M. S. Ghahfarokhi, M. B. Rezaee et al., “Chemical composition and antiaflatoxigenic activity of Carum carvi L., Thymus vulgaris and Citrus aurantifolia essential oils,” Food Control, vol. 20, no. 11, pp. 1018–1024, 2009. View at Publisher · View at Google Scholar · View at Scopus
  175. G. N. Qazi, K. L. Bedi, R. K. Johri et al., “Bioavailability enhancing activity of Carum carvi extracts and fractions thereof,” United States Patent Number, US20030228381A1, 2003.
  176. A. N. Makheja and J. M. Bailey, “Antiplatelet constituents of garlic and onion,” Agents and Actions, vol. 29, no. 3-4, pp. 360–363, 1990. View at Google Scholar · View at Scopus
  177. K. Prasad, V. A. Laxdal, M. Yu, and B. L. Raney, “Antioxidant activity of allicin, an active principle in garlic,” Molecular and Cellular Biochemistry, vol. 148, no. 2, pp. 183–189, 1995. View at Publisher · View at Google Scholar · View at Scopus
  178. L. Y. Chung, “The antioxidant properties of garlic compounds: alyl cysteine, alliin, allicin, and allyl disulfide,” Journal of Medicinal Food, vol. 9, no. 2, pp. 205–213, 2006. View at Publisher · View at Google Scholar · View at Scopus
  179. S. Ankri and D. Mirelman, “Antimicrobial properties of allicin from garlic,” Microbes and Infection, vol. 1, no. 2, pp. 125–129, 1999. View at Publisher · View at Google Scholar · View at Scopus
  180. Y. Cai, R. Wang, F. Pei, and B. B. Liang, “Antibacterial activity of allicin alone and in combination with β-lactams against Staphylococcus spp. and Pseudomonas aeruginosa,” Journal of Antibiotics, vol. 60, no. 5, pp. 335–338, 2007. View at Publisher · View at Google Scholar · View at Scopus
  181. K. Hirsch, M. Danilenko, J. Giat et al., “Effect of purified allicin, the major ingredient of freshly crushed garlic, on cancer cell proliferation,” Nutrition and Cancer, vol. 38, no. 2, pp. 245–254, 2000. View at Google Scholar · View at Scopus
  182. N. S. Kang, E. Y. Moon, C. G. Cho, and S. Pyo, “Immunomodulating effect of garlic component, allicin, on murine peritoneal macrophages,” Nutrition Research, vol. 21, no. 4, pp. 617–626, 2001. View at Publisher · View at Google Scholar · View at Scopus
  183. J. K. Grover, S. Yadav, and V. Vats, “Medicinal plants of India with anti-diabetic potential,” Journal of Ethnopharmacology, vol. 81, no. 1, pp. 81–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  184. A. Eidi, M. Eidi, and E. Esmaeili, “Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic rats,” Phytomedicine, vol. 13, no. 9-10, pp. 624–629, 2006. View at Publisher · View at Google Scholar · View at Scopus
  185. J. P. Anthony, L. Fyfe, and H. Smith, “Plant active components-a resource for antiparasitic agents?” Trends in Parasitology, vol. 21, no. 10, pp. 462–468, 2005. View at Publisher · View at Google Scholar · View at Scopus
  186. S. R. Davis, “An overview of the antifungal properties of allicin and its breakdown products—the possibility of a safe and effective antifungal prophylactic,” Mycoses, vol. 48, no. 2, pp. 95–100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  187. A. Ogita, K. I. Fujita, M. Taniguchi, and T. Tanaka, “Enhancement of the fungicidal activity of amphotericin B by allicin, an allyl-sulfur compound from garlic, against the yeast Saccharomyces cerevisiae as a model system,” Planta Medica, vol. 72, no. 13, pp. 1247–1250, 2006. View at Publisher · View at Google Scholar · View at Scopus
  188. H. Borjihan, A. Ogita, K. I. Fujita, E. Hirasawa, and T. Tanaka, “The vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans and its enhancement by allicin,” Journal of Antibiotics, vol. 62, no. 12, pp. 691–697, 2009. View at Publisher · View at Google Scholar · View at Scopus
  189. T. H. Tsai, P. J. Tsai, and S. C. Ho, “Antioxidant and anti-inflammatory activities of several commonly used spices,” Journal of Food Science, vol. 70, no. 1, pp. C93–C97, 2005. View at Google Scholar · View at Scopus
  190. E. A. Wilson and B. Demmig-Adams, “Antioxidant, anti-inflammatory, and antimicrobial properties of garlic and onions,” Nutrition and Food Science, vol. 37, no. 3, pp. 178–183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  191. R. Naithani, L. C. Huma, L. E. Holland et al., “Antiviral activity of phytochemicals: a comprehensive review,” Mini-Reviews in Medicinal Chemistry, vol. 8, no. 11, pp. 1106–1133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  192. A. Ogita, K. Hirooka, Y. Yamamoto et al., “Synergistic fungicidal activity of Cu2+ and allicin, an allyl sulfur compound from garlic, and its relation to the role of alkyl hydroperoxide reductase 1 as a cell surface defense in Saccharomyces cerevisiae,” Toxicology, vol. 215, no. 3, pp. 205–213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  193. A. Ogita, K. I. Fujita, and T. Tanaka, “Enhancement of the fungicidal activity of amphotericin B by allicin: effects on intracellular ergosterol trafficking,” Planta Medica, vol. 75, no. 3, pp. 222–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  194. A. Ogita, M. Yutani, K. I. Fujita, and T. Tanaka, “Dependence of vacuole disruption and independence of potassium ion efflux in fungicidal activity induced by combination of amphotericin B and allicin against Saccharomyces cerevisiae,” The Journal of Antibiotics, vol. 63, no. 12, pp. 689–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  195. S. Patil, R. P. Dash, S. Anandjiwala, and M. Nivsarkar, “Simultaneous quantification of berberine and lysergol by HPLC-UV: evidence that lysergol enhances the oral bioavailability of berberine in rats,” Biomedical Chromatography, vol. 26, no. 10, pp. 1170–1175, 2012. View at Publisher · View at Google Scholar
  196. J. A. Vinson, H. Al Kharrat, and L. Andreoli, “Effect of Aloe vera preparations on the human bioavailability of vitamins C and E,” Phytomedicine, vol. 12, no. 10, pp. 760–765, 2005. View at Publisher · View at Google Scholar · View at Scopus
  197. G. R. Gokaraju and R. R. Gokaraju, “Bioavailability/bioefficacy enhancing activity of Stevia rebaudiana and extracts and fractions and compounds thereof,” Date of Publication: 06/05/2010. United States Patent Number, US20100112101A1, 2010.
  198. W. Zhang and L. Y. Lim, “Effects of spice constituents on P-glycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro,” Drug Metabolism and Disposition, vol. 36, no. 7, pp. 1283–1290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  199. W. Zhang, T. M. C. Tan, and L. Y. Lim, “Impact of curcumin-induced changes in P-glycoprotein and CYP3A expression on the pharmacokinetics of peroral celiprolol and midazolam in rats,” Drug Metabolism and Disposition, vol. 35, no. 1, pp. 110–115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  200. B. H. Pavithra, N. Prakash, and K. Jayakumar, “Modification of pharmacokinetics of norfloxacin following oral administration of curcumin in rabbits,” Journal of Veterinary Science, vol. 10, no. 4, pp. 293–297, 2009. View at Google Scholar · View at Scopus
  201. Z. Q. Liu, H. Zhou, L. Liu et al., “Influence of co-administrated sinomenine on pharmacokinetic fate of paeoniflorin in unrestrained conscious rats,” Journal of Ethnopharmacology, vol. 99, no. 1, pp. 61–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  202. K. Chan, Z. Q. Liu, Z. H. Jiang et al., “The effects of sinomenine on intestinal absorption of paeoniflorin by the everted rat gut sac model,” Journal of Ethnopharmacology, vol. 103, no. 3, pp. 425–432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  203. J. D. Lambert, J. Hong, G. Y. Yang, J. Liao, and C. S. Yang, “Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations,” The American Journal of Clinical Nutrition, vol. 81, no. 1, pp. 284S–291S, 2005. View at Google Scholar · View at Scopus
  204. M. S. Kurzer and X. Xu, “Dietary phytoestrogens,” Annual Review of Nutrition, vol. 17, pp. 353–381, 1997. View at Publisher · View at Google Scholar · View at Scopus
  205. X. Li and J. S. Choi, “Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats,” International Journal of Pharmaceutics, vol. 337, no. 1-2, pp. 188–193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  206. J. D. Lambert, S. J. Kwon, J. Ju et al., “Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate,” Carcinogenesis, vol. 29, no. 10, pp. 2019–2024, 2008. View at Publisher · View at Google Scholar · View at Scopus
  207. H. C. Upadhyay, G. R. Dwivedi, M. P. Darokar, V. Chaturvedi, and S. K. Srivastava, “Bioenhancing and antimycobacterial agents from Ammannia multiflora,” Planta Medica, vol. 78, pp. 79–81, 2012. View at Google Scholar
  208. L. Cruz, G. Castañeda-Hernández, and A. Navarrete, “Ingestion of chilli pepper (Capsicum annuum) reduces salicylate bioavailability after oral aspirin administration in the rat,” Canadian Journal of Physiology and Pharmacology, vol. 77, no. 6, pp. 441–446, 1999. View at Google Scholar · View at Scopus
  209. H. S. López, L. G. Olvera, R. A. Jiménez, C. G. Olvera, and F. J. Gómez, “Administration of ciprofloxacin and capsaicin in rats to achieve higher maximal serum concentrations,” Arzneimittel-Forschung/Drug Research, vol. 57, no. 5, pp. 286–290, 2007. View at Google Scholar · View at Scopus
  210. A. Bouraoui, A. Toumi, H. Ben Mustapha, and J. L. Brazier, “Effects of capsicum fruit on theophylline absorption and bioavailability in rabbits,” Drug-Nutrient Interactions, vol. 5, no. 4, pp. 345–350, 1988. View at Google Scholar · View at Scopus
  211. R. J. Nijveldt, E. Van Nood, D. E. C. Van Hoorn, P. G. Boelens, K. Van Norren, and P. A. M. Van Leeuwen, “Flavonoids: a review of probable mechanisms of action and potential applications,” American Journal of Clinical Nutrition, vol. 74, no. 4, pp. 418–425, 2001. View at Google Scholar · View at Scopus
  212. S. L. Hsiu, Y. C. Hou, Y. H. Wang, C. W. Tsao, S. F. Su, and P. D. L. Chao, “Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats,” Life Sciences, vol. 72, no. 3, pp. 227–235, 2002. View at Publisher · View at Google Scholar · View at Scopus
  213. J. S. Choi and X. Li, “Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits,” International Journal of Pharmaceutics, vol. 297, no. 1-2, pp. 1–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  214. S. C. Shin, J. S. Choi, and X. Li, “Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats,” International Journal of Pharmaceutics, vol. 313, no. 1-2, pp. 144–149, 2006. View at Publisher · View at Google Scholar · View at Scopus
  215. J. S. Choi, Y. J. Piao, and K. W. Kang, “Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin,” Archives of Pharmacal Research, vol. 34, no. 4, pp. 607–613, 2011. View at Publisher · View at Google Scholar · View at Scopus
  216. Y. H. Wang, P. D. L. Chao, S. L. Hsiu, K. C. Wen, and Y. C. Hou, “Lethal quercetin-digoxin interaction in pigs,” Life Sciences, vol. 74, no. 10, pp. 1191–1197, 2004. View at Publisher · View at Google Scholar · View at Scopus
  217. J. S. Choi, B. W. Jo, and Y. C. Kim, “Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 57, no. 2, pp. 313–318, 2004. View at Publisher · View at Google Scholar · View at Scopus
  218. J. S. Choi and H. K. Han, “The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits,” Journal of Pharmacy and Pharmacology, vol. 56, no. 12, pp. 1537–1542, 2004. View at Publisher · View at Google Scholar · View at Scopus
  219. K. A. Kim, P. W. Park, and J. Y. Park, “Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers,” European Journal of Clinical Pharmacology, vol. 65, no. 6, pp. 609–614, 2009. View at Publisher · View at Google Scholar · View at Scopus
  220. L. Xiuguo and J. S. Choi, “Effects of quercetin on the pharmacokinetics of etoposide after oral or intravenous administration of etoposide in rats,” Anticancer Research, vol. 29, no. 4, pp. 1411–1416, 2009. View at Google Scholar · View at Scopus
  221. A. Kale, S. Gawande, S. Kotwal et al., “Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract,” Phytotherapy Research, vol. 24, no. 1, pp. S48–S55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  222. C. H. Yeum and J. S. Choi, “Effect of naringin pretreatment on bioavailability of verapamil in rabbits,” Archives of Pharmacal Research, vol. 29, no. 1, pp. 102–107, 2006. View at Google Scholar · View at Scopus
  223. H. S. Park, J. U. H. Oh, J. H. Lee, and Y. J. Lee, “Minor effects of the Citrus flavonoids naringin, naringenin and quercetin, on the pharmacokinetics of doxorubicin in rats,” Pharmazie, vol. 66, no. 6, pp. 424–429, 2011. View at Publisher · View at Google Scholar · View at Scopus
  224. R. A. Dixon and C. L. Steele, “Flavonoids and isoflavonoids—a gold mine for metabolic engineering,” Trends in Plant Science, vol. 4, no. 10, pp. 394–400, 1999. View at Publisher · View at Google Scholar · View at Scopus
  225. P. Hodek, P. Trefil, and M. Stiborová, “Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450,” Chemico-Biological Interactions, vol. 139, no. 1, pp. 1–21, 2002. View at Publisher · View at Google Scholar · View at Scopus
  226. J. Dupuy, G. Larrieu, J. F. Sutra, A. Lespine, and M. Alvinerie, “Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin,” Veterinary Parasitology, vol. 112, no. 4, pp. 337–347, 2003. View at Publisher · View at Google Scholar · View at Scopus
  227. H. A. Bardelmeijer, J. H. Beijnen, K. R. Brouwer et al., “Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein,” Clinical Cancer Research, vol. 6, no. 11, pp. 4416–4421, 2000. View at Google Scholar · View at Scopus
  228. J. S. Choi and H. K. Han, “Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats,” International Journal of Pharmaceutics, vol. 305, no. 1-2, pp. 122–128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  229. S. C. Lim and J. S. Choi, “Effects of naringin on the pharmacokinetics of intravenous paclitaxel in rats,” Biopharmaceutics and Drug Disposition, vol. 27, no. 9, pp. 443–447, 2006. View at Publisher · View at Google Scholar · View at Scopus
  230. S. W. Cho, J. S. Lee, and S. H. Choi, “Enhanced oral bioavailability of poorly absorbed drugs. I. Screening of absorption carrier for the ceftriaxone complex,” Journal of Pharmaceutical Sciences, vol. 93, no. 3, pp. 612–620, 2004. View at Publisher · View at Google Scholar · View at Scopus
  231. P. T. Kekuda, B. C. Nishanth, S. V. Praveen Kumar, D. Kamal, M. Sandeep, and H. K. Megharaj, “Cow urine concentrate: a potent agent with antimicrobial and anthelmintic activity,” Journal of Pharmacy Research, vol. 3, pp. 1025–1027, 2010. View at Google Scholar
  232. A. Khan and V. K. Srivastava, “Antitoxic and bioenhancing role of kamdhenu ark (cow urine distillate) on fertilitty rate of male mice (Mus musculus) affected by cadmium chloride toxicity,” International Journal of Cow Science, vol. 1, pp. 43–46, 2005. View at Google Scholar
  233. J. A. Ganaie and V. K. Shrivastava, “Effects of gonadotropin releasing hormone conjugate immunization and bioenhancing role of Kamdhenu ark on estrous cycle, serum estradiol and progesterone levels in female Mus musculus,” Iranian Journal of Reproductive Medicine, vol. 8, no. 2, pp. 70–75, 2010. View at Google Scholar · View at Scopus
  234. J. A. Ganaie, V. Gautam, and V. K. Shrivastava, “Effects of kamdhenu ark and active immunization by gonadotropin releasing hormone conjugate (GnRH-BSA) on gonadosomatic indices (GSI) and sperm parameters in male Mus musculus,” Journal of Reproduction and Fertility, vol. 12, no. 1, pp. 3–7, 2011. View at Google Scholar
  235. H. K. Han, “The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs,” Expert Opinion on Drug Metabolism and Toxicology, vol. 7, no. 6, pp. 721–729, 2011. View at Publisher · View at Google Scholar · View at Scopus